medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2010, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2010; 55 (1)

Triamcinolone: Effecive treatment for chalazia?

Aguilar ACL, Sabagh MJE

Language: Spanish
References: 15
Page: 29-32
PDF size: 304.79 Kb.


ABSTRACT

Purpose: To evaluate the safety and efficacy of intralesional triamcinolone acetonide injection in primary and recurrent Chalazia. Design: Prospective longitudinal consecutive case series. Material and methods: Intralesional injection of 0.1 mL to 0.2 mL of triamcinolone acetonide (40 mg/mL). Participants: Patients with primary or recurrent Chalazia, with a range of age between 10 and 75 years old, treated at the Orbit and Oculoplastic Department of the American British Cowdray Hospital, Campus Santa Fe, between January 1st 2007 and January 31st 2009. Data regarding: Lesion size, digital color photography regression or recurrence. Results: 38 patients were included, 40 lids of which 20 were right and 20 were left. Sex distribution was predominantely male (62.5%, n = 25). Average age was 39.2 ± 20.2 years. No complications. Conclusions: Triamcinolone injection is an effective treatment in Chalazia, achieving lesion regression. Most cases resolve with 1 injection. It may be considered as a first treatment in cases when diagnosis is straightforward. It is a safe treatment in pregnant women. Cost is accessible.


REFERENCES

  1. Ben Simon GJ, HUang L. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: It is really effective? Ophthalmology 2005; 112 (5): 913-917.

  2. Khurana AK, Ahluwalia BK. Chalazion therapy. Intralesional steroids versus incision and curettage. Acta Ophthalmol (Copenh) 1998; 66 (3): 352-354.

  3. Kaimbo WaKaimbo D, Nkidiaka MC. Intralesional corticosteroid injection in the treatment of chalazion. J Fr Ophthalmol 2004; 27 (2): 149-153.

  4. Hosal BM, Zilelioglu G. Ocular complication of intralesional corticosteroid injection of Chalazia. Eur J Ophthalmol 2003; 13 (9-10): 798-799.

  5. Ho SY, Lai JS. Subcutaneous steroid injection as treatment for chalazia: Prospective case series. Hong Kong Med J 2002; 8 (1): 18-20.

  6. Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J 2001; 22 (11): 968-972.

  7. Pizzarello LD, Jakobiec FA. Intralesional corticosteroid therapy of chalazia. Am J Ophthalmic 1978; 85 (6): 818-821

  8. Korn EL. Laser chalazia removal. Ophthalmic Surg 1998; 19 (6): 428-431.

  9. Domarus DV, HInzpeter EN. The clinical misdiagnosis of chalazion 1976; 168 (02): 175-181.

  10. Sarkisian KA, Gusev OA. Economic effectiveness of the introduction of a new method of conservative treatment of chalazion. Vestn Oftalmol 1989; 105 (1): 54-55.

  11. Rozival P, Hejcmanova D. Treatment of chronic chalazion with kenalog injections. Cesk Oftalmol 1985; 41 (1): 35-36.

  12. Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: Triamcinolone acetonide injection, incision and curettage and treatment with hot compresses. Clin Experiment Ophthalmol 2007; 35 (8): 706-712.

  13. Camara CHG, Ibarra PN. Estudio prospectivo sobre la eficacia de la betametasona en el tratamiento del chalazión. Rev Mex Oftalmol 2006; 80 (2): 83-85.

  14. Chung CF, Lai SJ. Subcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazion. Hong Kong Med J 2006; 12 (4): 278-281.

  15. Castren J, Stenborg T.Corticoid injection of chalazia. Acta Ophthalmol (Copenh) 1983; 61 (5): 938-942.




2020     |     www.medigraphic.com